Restoring the resting potential brings maturity to induced stem cell-derived human cardiac myocytes

Reprogramming of mature human cells to produce the equivalent of embryonic stem cells offers exciting possibilities for therapeutic tissue repair and artificial organs. A more immediate benefit is the possibility of testing potential new drugs and other therapies in human cells of any type that can easily be created in vitro without the use of human blastocysts and with a minimum of invasive procedures in patients.

Publication

Total
1
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Role of sodium/calcium exchange in heart failure-induced arrhythmias

Next Article

At Home in the Law: How the Domestic Violence Revolution Is Transforming Privacy

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×